Correlation Between Oracle and Biotechnology Portfolio

Can any of the company-specific risk be diversified away by investing in both Oracle and Biotechnology Portfolio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oracle and Biotechnology Portfolio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oracle and Biotechnology Portfolio Biotechnology, you can compare the effects of market volatilities on Oracle and Biotechnology Portfolio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oracle with a short position of Biotechnology Portfolio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oracle and Biotechnology Portfolio.

Diversification Opportunities for Oracle and Biotechnology Portfolio

0.75

Correlation Coefficient

Oracle  Biotechnology Portfolio

Poor diversification

The 3 months correlation between Oracle and Biotechnology is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Oracle and Biotechnology Portfolio Biotec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Portfolio and Oracle is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oracle are associated (or correlated) with Biotechnology Portfolio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Portfolio has no effect on the direction of Oracle i.e., Oracle and Biotechnology Portfolio go up and down completely randomly.

Pair Corralation between Oracle and Biotechnology Portfolio

Given the investment horizon of 90 days Oracle is expected to under-perform the Biotechnology Portfolio. In addition to that, Oracle is 2.3 times more volatile than Biotechnology Portfolio Biotechnology. It trades about -0.03 of its total potential returns per unit of risk. Biotechnology Portfolio Biotechnology is currently generating about -0.06 per unit of volatility. If you would invest  2,062  in Biotechnology Portfolio Biotechnology on December 1, 2024 and sell it today you would lose (99.00) from holding Biotechnology Portfolio Biotechnology or give up 4.8% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Oracle  vs.  Biotechnology Portfolio Biotec

Oracle

Risk-Adjusted Performance

Very Weak

Over the last 90 days Oracle has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Oracle is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Biotechnology Portfolio

Risk-Adjusted Performance

Very Weak

Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Biotechnology Portfolio is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Oracle and Biotechnology Portfolio

The main advantage of trading using opposite Oracle and Biotechnology Portfolio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oracle position performs unexpectedly, Biotechnology Portfolio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Portfolio will offset losses from the drop in Biotechnology Portfolio's long position.

The idea behind Oracle and Biotechnology Portfolio Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.